Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Molina Healthcare's yield on cost for the quarter that ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Molina Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
STU:MHG's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Plans industry.
Industry Median: 3.33 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Molina Healthcare 5-Year Yield-on-Cost % Related Terms
STU:MHG vs OSCR, ALHC, PGNY: 5-Year Yield-on-Cost % Comparison
For the Healthcare Plans subindustry, Molina Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Molina Healthcare 5-Year Yield-on-Cost % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Molina Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Molina Healthcare's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Molina Healthcare (STU:MHG) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Molina Healthcare and its competitors. According to the industry distribution chart, Molina Healthcare ranks #999999 out of 9 companies in the Healthcare Plans industry.
Is Molina Healthcare's 5-Year Yield-on-Cost % too high?
Molina Healthcare's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Molina Healthcare ranks #999999 out of 9 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Molina Healthcare has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Molina Healthcare's 5-Year Yield-on-Cost % compare to OSCR and ALHC?
According to the Healthcare Plans industry distribution chart, Molina Healthcare ranks #999999 out of 9 companies for 5-Year Yield-on-Cost %. This places Molina Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Plans company?
The median 5-Year Yield-on-Cost % among Healthcare Plans companies is 3.33, based on 9 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Molina Healthcare and its competitors. For the Healthcare Plans industry, the median 5-Year Yield-on-Cost % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Molina Healthcare's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molina Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Molina Healthcare (STU:MHG) is currently considered Significantly Undervalued. The stock's GF Value™ is €328.66, compared to a current price of €169.80 — trading 48.3% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Molina Healthcare's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Molina Healthcare (STU:MHG), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Molina Healthcare (STU:MHG) Overvalued in 2026?
Based on GuruFocus' analysis, Molina Healthcare stock appears to be undervalued.
The current stock price of €169.80 is trading 48.3% below its estimated GF Value™ of €328.66.
GuruFocus considers Molina Healthcare to be Significantly Undervalued.
Key valuation signals for STU:MHG:
5-Year Yield-on-Cost %: 0.00
GF Value™: €328.66 vs. price of €169.80 (48.3% below fair value)
No single metric tells the full story. See the STU:MHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
77GF Score
Get the complete analysis for STU:MHG
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:MHG has been successfully added to your 
